Oric Pharmaceuticals (ORIC)
(Delayed Data from NSDQ)
$9.99 USD
+0.25 (2.51%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $9.99 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Oric Pharmaceuticals, Inc. has a market cap of $830.51M, which represents its share price of $9.75 multiplied by its outstanding shares number of 85.22M. As a small-cap company, ORIC's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ORIC 9.99 +0.25(2.51%)
Will ORIC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ORIC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ORIC
Oric Pharmaceuticals, Inc. (ORIC) Now Trades Above Golden Cross: Time to Buy?
Oric Pharmaceuticals, Inc. (ORIC) is a Great Momentum Stock: Should You Buy?
ORIC: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Oric Pharmaceuticals (ORIC) Rating Upgrade to Buy
Does Oric Pharmaceuticals (ORIC) Have the Potential to Rally 104.99% as Wall Street Analysts Expect?
What Makes Oric Pharmaceuticals, Inc. (ORIC) a Strong Momentum Stock: Buy Now?
Other News for ORIC
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC ...
Oric Pharmaceuticals initiated with bullish view at Ladenburg, here's why
ORIC: New Coverage Initiated with a Buy Rating and $15 Price Target | ORIC Stock News
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC ...
Insider Sell: Dominic Piscitelli Sells 20,000 Shares of ORIC Pharmaceuticals Inc (ORIC)